This Week on Drug Topics: July 12 to July 16

Here’s a preview of the featured content to watch for this week on Drug Topics®.

Coronavirus Research News

The CDC estimates that 63.7% of US adults have received at least 1 COVID-19 vaccine as of this article’s press time. Keeping up with pandemic news is more important than ever, so check back to Drug Topics® to stay informed on the latest coronavirus-related news and research.

Read more coronavirus-related news.

The Latest from Total Pharmacy®: Getting Paid for Medication Management Services

The mechanics of getting paid for nondispensing services are shrouded in myths and lies. Conventional wisdom says pharmacists have always given away their clinicial, nondispensing services and payers won’t reimburse what they can get for free.

Read more on Total Pharmacy.

Drug Topics® Journal, July 2021 Digital Edition

The July 2021 digital edition of Drug Topics Journal is now available on DrugTopics.com. In this issue, you’ll find great insights into the latest pharmacy trends in independent community practice, diabetes, respiratory and autoimmune diseases, and more.

Read the latest issue of Drug Topics Journal.

Medical World News: ADA Scientific Session Coverage

Stay tuned for Drug Topics® coverage of the American Diabetes Association’s 81st Scientific Sessions, including interviews of study investigators from phase 3 clinical trials on faricimab, the first treatment that targets two pathways of diabetic macular edema (DME).

View more ADA 2021 coverage.

On Demand: What You Don't Know Can Cost You: Simple Ways to Make Data-Driven Decisions in Your Pharmacy

In this podcast episode with Jeff Harrell, PharmD, learn simple tools and tips to optimize profitability and streamline operations using objective data straight from your pharmacy.

Listen to more podcast episodes.

In Case You Missed It: COVID-19 Antibody Response in Fully Vaccinated Patients With Cancer

Patients with cancer with complete COVID-19 vaccinations demonstrated a high rate of antibodies, according to the study.

Read more